For example, in subcutaneous glioma cells treated with radiotherapy, the GLUT1 inhibitor apigenin reduced cell stemness and DNA damage repair by inhibiting the NF-κB/hif-1α/GLUT1 pathway, facilitating radiosensitivity 30. This evidence concerns the gene SLC2A1 and central nervous system cancer.